Narrow Therapeutic Index Drugs: Stricter Bioequivalence Requirements Explained
Narrow therapeutic index drugs require stricter bioequivalence standards to ensure patient safety. Learn how the FDA, EMA, and Health Canada regulate generics of critical medications like warfarin and levothyroxine.